| Previous close | 1.2300 |
| Open | 1.2300 |
| Bid | 0.0000 |
| Ask | 3.2000 |
| Strike | 180.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.6000 - 1.2300 |
| Contract range | N/A |
| Volume | |
| Open interest | 14 |
ZacksLilly Gets FDA Approval for Eczema Drug Ebglyss
The FDA approves Lilly's Ebglyss based on data from ADvocate 1, ADvocate 2 and ADhere studies.
Insider MonkeyEli Lilly and Company (LLY): Among Morgan Stanley’s Best Stock Picks for 2025
We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Morgan Stanley’s other stock picks. The tail end of 2024 is seeing a market shift in the stock market as […]
- Zacks
Top Stock Picks for Week of September 16, 2024
One of the Largest Pharmaceutical Companies and an Emerging Growth Company are Profiled.
© 2024 Yahoo. All rights reserved.